🔗 Share this article

While the US undertakes historic adjustments to its vaccination schedules, one figure appears unexpectedly: Høeg, a Danish American physician and public health researcher who rose to prominence by questioning Covid vaccines during the pandemic and has focused upon possible fatalities following COVID-19 immunization in her recent time at the Food and Drug Administration.

Planned Changes to Childhood Immunization Program

Agency leaders had intended to unveil sweeping changes to the childhood immunization program earlier this month, bringing the US with the Danish immunization schedule, it is understood – a substantial departure that would place the US out of alignment with much of the world with little proof for public health gain. This reveal has been delayed until the coming year.

Rather than the top vaccines chief, Tracy Beth Høeg is listed to address the audience at the event. She was newly appointed interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth person to lead the office this calendar year.

Consolidating Power at the Agency

The acting appointment may indicate a tighter collaboration between the drug and biologics centers as Dr. Høeg and Prasad consolidate power at the agency – and it points to a greater focus upon rolling back long-standing immunizations at the FDA.

The new acting director has repeatedly called for ending specific childhood vaccine recommendations in the US to become more similar to the Danish model, a country with nationalized medicine and a citizenry approximately the size of the state of Wisconsin.

To date comments, she has kept her attention on vaccination policy – usually the responsibility of Prasad, director of the FDA’s CBER – as opposed to drug regulation.

Concerns Over Background

Dr. Høeg has no apparent experience in drug development, oversight or management, which has been customary for former directors of the Center for Biologics Evaluation and Research. She has worked at the FDA as a top consultant to the agency head and the vaccine center since earlier this year.

“She doesn’t seem to have any of the qualifications” for running the CDER, stated Jonathan Howard. “She lacks experience running a scientific study. She lacks experience in running a sizeable institution. She is not an expert in industry regulation.”

Former directors of CBER would “understand laws and regulations and the underlying principles of medication creation”, commented Janet Woodcock. “Frankly, she has not acquired the type of experience that previous people who headed CBER have had.”

This division has an immense workload at the agency, the former commissioner emphasized.

“Many people just zeroes in on the new drug program, but the generic program authorizes numerous off-brand pharmaceuticals. There’s a biologic copycat branch, non-prescription drug unit and more, and all of those need to be managed,” Woodcock noted. “The thing you overlook, that is precisely what that I always told people is going to cause problems.”

There is also, a significant management component to the position, which manages more than 5,000 staff members. “It is a enormous administrative position, if you execute it properly,” Woodcock added.

Response and Contentious Initiatives

Regarding concerns about Dr. Høeg's fitness for the role and whether this appointment signifies greater collaboration among agency officials on vaccines, a representative said that the “inquiries are based on flawed presumptions”.

“Her experience aligns with the responsibilities of her job,” the official explained, citing the time Dr. Høeg spent counseling the agency head on “pharmaceutical safety and regulatory science, including predictive safety algorithms and immunization monitoring”.

As the temporary head, Høeg assumes responsibility for the agency head's controversial fast-track approval initiative, a controversial rapid drug-approval program that apparently worried her preceding directors. “How are these therapies being chosen for this expedited pathway? Who takes the calls?” Dr. Howard said. “There is a lot of confidentiality happening at the FDA right now.”

Broadly speaking, he remarked, “the Food and Drug Administration looks to be trending towards less stringent oversight of all drugs, with the exception of shots.”

Documented Track Record on Vaccines

Regarding vaccines, Dr. Høeg has a more documented, if troubling, track record, some experts observe. She published a study using unverified public submissions to assess the rate of heart inflammation after Covid immunization. She consulted for the Florida surgeon general Dr. Joseph Ladapo, who reportedly have changed statistics to imply COVID-19 vaccines are more dangerous than they are.

Part of her “desired changes” for the current government featured revising guidelines for recently developed shots and discontinuing “unnecessary” vaccines, she stated after the election on a audio program. At the agency, Høeg has allegedly proposed barring teenage boys from receiving Covid vaccinations.

“She’s an thorough ideologue who begins with her beliefs and works backwards to fit the science in a very disingenuous, untruthful fashion,” Dr. Howard stated.

Consolidating Power and a “Revenge Tour”

Dr. Høeg aligned with other skeptics, {like|